Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junhui Wang

Showing results (1-10 of 412) with videos related to

Pageof 42
Sort By:
Frontiers in Molecular Neuroscience|March 26, 2025
Editorial: Molecular pathology, biomarkers and therapeutics of brain tumor and neurodegenerative diseaseJunhui Wang
Frontiers in Molecular Neuroscience|March 31, 2023
Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectivesJunhui Wang
Frontiers in Psychology|June 1, 2022
The Design and Development of the Internet-Based System for Testing and Analyzing the Psychological and Physiological Responses During Creative LearningJunhui Wang
Brain Sciences|May 27, 2026
New Advances in Neuroimmunology and NeuroinflammationJunhui Wang
BMC Bioinformatics|August 1, 2019
IRESpy: an XGBoost model for prediction of internal ribosome entry sitesJunhui Wang, Michael Gribskov
Medicine|October 30, 2020
The COVID-19 research landscape: Measuring topics and collaborations using scientific literatureJunhui Wang, Na Hong
Medicine|June 7, 2019
Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma: A system review and meta-analysisJianxin Chen, Junhui Wang
Frontiers in Oncology|February 13, 2023
STK11 loss and SMARCB1 deficiency mutation in a dedifferentiated lung cancer patient present response to neo-adjuvant treatment with pembrolizumab and platinum doublet: A case reportJianxin Chen, Junhui Wang
Medicine|October 14, 2018
Risk of regorafenib-induced cardiovascular events in patients with solid tumors: A systematic review and meta-analysisJianxin Chen, Junhui Wang
Frontiers in Pharmacology|August 2, 2023
Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitorsJianxin Chen, Junhui Wang
Pageof 42

Showing results (1-10 of 412) with videos related to

Sort By:
Pageof 42
Frontiers in Molecular Neuroscience|March 26, 2025
Editorial: Molecular pathology, biomarkers and therapeutics of brain tumor and neurodegenerative diseaseJunhui Wang
Frontiers in Molecular Neuroscience|March 31, 2023
Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectivesJunhui Wang
Frontiers in Psychology|June 1, 2022
The Design and Development of the Internet-Based System for Testing and Analyzing the Psychological and Physiological Responses During Creative LearningJunhui Wang
Brain Sciences|May 27, 2026
New Advances in Neuroimmunology and NeuroinflammationJunhui Wang
BMC Bioinformatics|August 1, 2019
IRESpy: an XGBoost model for prediction of internal ribosome entry sitesJunhui Wang, Michael Gribskov
Medicine|October 30, 2020
The COVID-19 research landscape: Measuring topics and collaborations using scientific literatureJunhui Wang, Na Hong
Medicine|June 7, 2019
Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma: A system review and meta-analysisJianxin Chen, Junhui Wang
Frontiers in Oncology|February 13, 2023
STK11 loss and SMARCB1 deficiency mutation in a dedifferentiated lung cancer patient present response to neo-adjuvant treatment with pembrolizumab and platinum doublet: A case reportJianxin Chen, Junhui Wang
Medicine|October 14, 2018
Risk of regorafenib-induced cardiovascular events in patients with solid tumors: A systematic review and meta-analysisJianxin Chen, Junhui Wang
Frontiers in Pharmacology|August 2, 2023
Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitorsJianxin Chen, Junhui Wang
Pageof 42